Company Info

Number of Employees

33500

Ticker

EVK (DB)

Revenue

$14,469.1

Evonik

CDMO, Excipients, Pharma Intermediates

Tagline

Power to Create

Overview

Evonik Industries supports patient-friendly health care with a number of product developments for the pharmaceutical industry and medical technology. The company is contracted by pharmaceutical companies to produce active ingredient precursors, active ingredients and highly potent active ingredients under strict quality specifications. Evonik also produces pharmaceutical amino acids that are used in life-saving infusions and in the production of active pharmaceutical ingredients. Additionally, the company offers technology appropriate for the body, such as tablet coatings that release active ingredients at a precisely specified time to optimize efficacy. Evonik Industries is headquartered in Essen, Germany and owned by RAG Foundation.

Company Services

Services/CapabilitiesCDMO

+ Biomanufacturing

cGMP Microbial Manufacturing

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Preformulation/Formulation
Process Development & Validation
Scale Up/Tech Transfer

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Drug Substance Manufacturing

Advanced Intermediates

+ Packaging

Carton Packaging
Prefilled Syringes/Cartridges/Pen Devices

Services/ProductsExcipients

Services/CapabilitiesPharma Intermediates

Contributors

Andrea Engel, Ph.D.

Philipp Heller, Ph.D.

Jane Meyer

Kristina Parrant

Cole Byvelds, P.Eng.

Maaike Everts, Ph.D.

Caroline Hand

Natalia Zisman

Jean-Luc Herbeaux, Ph.D.

Contributions

New Polymer-Lipid Delivery System for mRNA

Q: What’s the key to being a leader in the industry?

Q: What important company milestone do you anticipate reaching in 2022?

Innovating at the Forefront of mRNA LNP Therapies

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Focus on Commercial Parenteral Manufacturing at Evonik

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin

About Us

That's Nice Staffing

More

Media Kit Donwload Current Issue

Your Account

Help

Contact Us Support

Nice Insight/That’s Nice

89 Fifth Avenue
Fifth Floor
New York
NY 10003-3020

New York – San Diego – Chicago
London – Frankfurt – Shanghai

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.